Stay updated with breaking news from Rekso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ekso Bionics (NASDAQ:EKSO – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $9.25 to $10.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Separately, StockNews.com raised shares of Ekso Bionics from a “sell” rating to a […] ....
Ekso Bionics (NASDAQ:EKSO – Get Free Report) issued its earnings results on Monday. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.04), Yahoo Finance reports. The company had revenue of $3.76 million for the quarter, compared to analysts’ expectations of $4.99 million. Ekso Bionics had a […] ....
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 253,000 shares, a decline of 32.2% from the January 15th total of 373,300 shares. Based on an average daily trading volume, of 180,100 shares, the short-interest ratio is […] ....
Ekso Bionics (NASDAQ:EKSO – Free Report) had its price target boosted by HC Wainwright from $9.00 to $10.00 in a research report report published on Monday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Ekso Bionics’ Q4 2023 earnings at ($0.11) EPS, FY2023 earnings at ($0.96) […] ....